Immunophotonics, Inc.
Pharmaceutical company · St. Louis, Missouri, United States
Immunophotonics, Inc. is a pharmaceutical company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2012. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2024.
Immunophotonics at a glance
What does Immunophotonics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2021 to 2023). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $1.5 million sold (2024).
Frequently asked questions about Immunophotonics
Where is Immunophotonics headquartered?
Immunophotonics, Inc. is headquartered in St. Louis, Missouri, United States.
What does Immunophotonics do?
Immunophotonics, Inc. is a pharmaceutical company.
When was Immunophotonics founded?
The earliest incorporation on record for Immunophotonics, Inc. is in 2012, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.